Checkpoint Inhibitors Appear to Reduce Skin Cancer Precursors
(MedPage Today) — Use of immune checkpoint inhibitor (ICI) therapy for cancer was associated with a significant reduction in actinic keratoses in a small prospective cohort study, indicating potential as an immuno-preventive strategy for high…
